CompletedNot Applicable

Virtual Reality Immersive Method for Spider (Phobia) Exposure Therapy (VIMSE)

Sweden100 participantsStarted 2015-08-01

Plain-language summary

The aim of this study is to examine the efficacy of virtual reality exposure therapy as a treatment for specific phobia (spiders). A gamified virtual reality simulation of one-session therapy (VR-OST) will be compared to the gold-standard treatment in the form of traditional one-session phobia treatment (OST) using in-vivo stimuli. This study was powered to detect a non-inferiority margin of a 2-point difference between groups.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Score of 10 or less in Behavioral Approach Test * Individual meeting DSM-5 criteria according to interview for primary diagnosis of specific phobia, spider * Swedish residency * Fluent in Swedish Exclusion Criteria: * Ongoing psychotherapy * Ongoing psychotropic medication (unless stabilized for three months) * Indication of suicidal ideation, as assessed by item 9 of the PHQ-9 * Meets criteria for alcohol or substance use disorder * Meets criteria for serious mental disorder, such as bipolar disorder, schizophrenia or psychosis * Balance and/or eyesight problems (such as lack of stereoscopic vision) that could interfere with VR treatment

What they're measuring

Behavioral Approach Test (BAT)

Timeframe: Change from baseline on BAT (1 week)

Behavioral Approach Test (BAT)

Timeframe: Change from baseline on BAT (12 week)

Behavioral Approach Test (BAT)

Timeframe: Change from baseline on BAT (52 week)

Trial details

NCT IDNCT02533310

SponsorStockholm University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-12

View on ClinicalTrials.gov More Phobia, Specific trials